Study Design
Subject Type
Human
Trial Design
Randomised, Controlled
Trial Duration
56 days
Participants
40 (40 completed)
Age Range
23-84 years
Efficacy
Intervention(s) Outcome
Melasma
Sign in to read for free
Melasma
Sign in to read for free
Side Effects
Intervention(s) Outcome
Skin Discomfort
Sign in to read for free
Skin Redness
Sign in to read for free
Study Summary
Sign in to read for free